0548-9601 : Neostigmine Methylsulfate .5 mg/ml Intravenous Injection


NDC: 0548-9601
Labeler: Amphastar Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name: Neostigmine Methylsulfate
Dosage Form: Intravenous Injection
Application #: ANDA209933
Rev. Date: 


NDC Package Codes:

  • 0548-9601-00: 10 CARTON IN 1 PACKAGE (0548‑9601‑00) > 1 VIAL, MULTI‑DOSE IN 1 CARTON > 10 ML IN 1 VIAL, MULTI‑DOSE
  • 0548-9601-01: 10 CARTON IN 1 PACKAGE (0548‑9601‑01) > 1 VIAL, MULTI‑DOSE IN 1 CARTON (0548‑9601‑00) > 10 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Neostigmine Methylsulfate

Dosage Strength:

  • .5 mg/mL

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0548-9602 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Amphastar Pharmaceuticals, Inc.
  • 0404-9925 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Henry Schein, Inc.
  • 0517-0033 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by American Regent, Inc.
  • 0517-0034 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by American Regent, Inc.
  • 0517-1133 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by American Regent, Inc.
  • 0517-1134 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by American Regent, Inc.
  • 0641-6076 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6077 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6140 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6141 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6149 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp.
  • 0641-6150 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp.
  • 0641-6240 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0641-6264 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0641-6265 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 14445-413 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Indoco Remedies Limited
  • 14445-414 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Indoco Remedies Limited
  • 23155-517 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
  • 23155-518 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
  • 25021-610 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0548-9601 QR Code

< Prev: 0548-9502Next: 0548-9602 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.